Texas is known for having some dedicated workers. Photo via Getty Images

Texas residents are among the most industrious workers in the country, according to WalletHub's annual "Hardest-Working States in America (2024)" study. The Lone Star State ranks No. 7 this year.

Despite still ranking in the top 10, though, Texas has seemingly become a little less driven over the last six years. Texas ranked No. 4 most industrious state for two years in a row starting in 2019, then slipped to No. 5 in 2021 and 2022, then to No. 6 in 2023. And here we've arrived at No. 7.

The 2024 report ranked each state based on two major categories: "Direct Work Factors," which cover average workweek hours, employment rates, and the rate of "idle youth" (a.k.a. the measure of 18 to 24-year-old residents who aren't enrolled in school, have no job, or a high school diploma or GED); and "Indirect Work Factors," such as the share of workers with multiple jobs, average commute times, and other employment data.

Outshining the Lone Star State as the No. 1 hardest-working state in America is North Dakota, with a score of 66.54 points out of a possible 100. Rounding out the top five are Alaska (No. 2), Nebraska (No. 3), Wyoming (No. 4), and South Dakota (No. 5).

Texas was less than 10 points away from the No. 1 spot, scoring 56.86 points, and ranked No. 4 nationally in the "Direct Work Factors" category. Unfortunately, the state suffered in the national "Indirect Work Factors" ranking and only came in at No. 31.

Texans have the second-longest workweeks in America, right behind Alaska, but the study doesn't give details on how long the average workweek is in Texas. The state also has the fifth-lowest annual volunteer hours per resident, likely because Texans are too busy at their day jobs (or are too exhausted after work) to volunteer their time anywhere else.

In May 2024, over 15.26 million people were part of the state’s civilian workforce (which excludes active-duty military personnel), according to the Texas Workforce Commission. May marked the 10th consecutive month where Texas set a record-high level for jobs growth.

“Texas continues to outpace the nation in nearly all industries and continues to increase the number of employed Texans,” said TWC Commissioner Representing Labor Alberto Treviño III. “With job opportunities increasing, students and job seekers have multiple resources to help navigate the job market and create a career pathway.”

Houston succeeded as the No. 27 most hardworking city in America in a separate WalletHub report from February 2024.

Being known for efficiency and productivity is a good reputation for Texas workers to hold, but WalletHub analyst Cassandra Happe emphasizes that taking time to relax and reset is equally important for sustaining a determined workforce.

"It’s undeniable that America has fostered a culture of hard work, with people working longer hours than residents of other developed countries and often leaving vacation time on the table," Happe said. "Working hard is commendable, but people in the hardest-working states may need to consider taking a break once in a while, as a lack of leisure time can have a negative impact on people’s physical and mental health."

The top 10 hardest working states are:

  • No. 1 – North Dakota
  • No. 2 – Alaska
  • No. 3 – Nebraska
  • No. 4 – Wyoming
  • No. 5 – South Dakota
  • No. 6 – Maryland
  • No. 7 – Texas
  • No. 8 – Colorado
  • No. 9 – New Hampshire
  • No. 10 – Kansas
The full report can be found on wallethub.com

.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Play it back: Houston home tech startup begins 2025 with fresh funding

HOUSTON INNOVATORS PODCAST EPISODE 272

One of the dozen or so Houston startups kicking of the new year with fresh funding is SmartAC.com, a company that's designed a platform that enables contractors in the HVAC and plumbing industries to monitor, manage, and optimize their maintenance memberships through advanced sensors, AI-driven diagnostics, and proactive alerts.

Last month, the SmartAC.com raised a follow-on round with support from local investor Mercury to continue growth and expansion of the product, which has evolved on many ways since the company launched in 2020, emerging from stealth with $10 million raised in a series A. In a May 2023 interview for the Houston Innovators Podcast, Founder and CEO Josh Teekell explained how he embraced the power of a pivot.

The company's sensors can monitor all aspects of air conditioning units and report back any issues, meaning homeowners have quicker and less costly repairs. While SmartAC.com started with providing the service and tech to homeowners directly, Teekell says he's had a greater interest in working with plumbers and HVAC companies who then deploy the technology to their customers.

"It became quite evident that homeowners don't care about air conditioning really at all until their system breaks," Teekell says on the show. "The technology is really built around giving those contractors as another way to gain a customer relationship and keep it."

Revisit the podcast episode below where Teekell talks about SmartAC.com's last raise.

SmartAC.com's previous round in 2023 — a $22 million series B — was used grow its team that goes out to deploy the technology and train the contractors on the platform.

"We've been very fortunate to get some of the biggest names in Houston on our cap table," Teekell says in the May 2023 conversation. "Since we're raising a bunch of money locally, everyone understands what a pain air conditioning can be."

Houston biotech company tests hard-to-fight cancer therapeutics

fighting cancer

A Houston-based, female-founded biotech company has developed a treatment that could prove to be an effective therapy for a rare blood cancer.

Cellenkos Therapeutics has completed promising Phase 1b testing of its Treg cell therapy, CK0804, in the fight against myelofibrosis. According to a news release from the Cellenkos team, the use of its cord-blood-derived therapeutics could signal a paradigm shift for the treatment of this hard-to-fight cancer.

Cellenkos was founded by MD Anderson Cancer Center physician and professor Simrit Parmar. Her research at the hospital displayed the ability of a unique subset of T cells’ capability to home in on a patient’s bone marrow, restoring immune balance, and potentially halting disease progression.

Myelofibrosis has long been treated primarily with JAK (Janus Kinase) inhibitors, medications that help to block inflammatory enzymes. They work by suppressing the immune response to the blood cancer, but don’t slow the progression of the malady. And they’re not effective for every patient.

“There is a significant need for new therapeutic options for patients living with myelofibrosis who have suboptimal responses to approved JAK inhibitors,” Parmar says. “We are greatly encouraged by the safety profile and early signs of efficacy observed in this patient cohort and look forward to continuing our evaluation of the clinical potential of CK0804 in our planned expansion cohort.”

The expansion cohort is currently enrolling patients with myelofibrosis. What exactly are sufferers dealing with? Myelofibrosis is a chronic disease that causes bone marrow to form scar tissue. This makes it difficult for the body to produce normal blood cells, leaving patients with fatigue, spleen enlargement and night sweats.

Myelofibrosis is rare, with just 16,000 to 18,500 people affected in the United States. But for patients who don’t respond well to JAKs, the prognosis could mean a shorter span than the six-year median survival rate outlined for the disease by Cleveland Clinic.

Helping myelofibrosis patients to thrive isn’t the only goal for Cellenkos right now.

The company seeks to aid people with rare conditions, particularly inflammatory and autoimmune disorders, with the use of CK0804, but also other candidates including one known as CK0801. The latter drug has shown promising efficacy in aplastic anemia, including transfusion independence in treated patients.

The company closed its $15 million series A round led by BVCF Management, based in Shanghai, in 2021. Read more here.

Pioneering Houston biotech startup expands to Brazil for next phase

On the Move

Houston biotech company Cemvita has expanded into Brazil. The company officially established a new subsidiary in the country under the same name.

According to an announcement made earlier this month, the expansion aims to capitalize on Brazil’s progressive regulatory framework, including Brazil’s Fuel of the Future Law, which was enacted in 2024. The company said the expansion also aims to coincide with the 2025 COP30, the UN’s climate change conference, which will be hosted in Brazil in November.

Cemvita utilizes synthetic biology to transform carbon emissions into valuable bio-based chemicals.

“For decades Brazil has pioneered the bioeconomy, and now the time has come to create the future of the circular bioeconomy,” Moji Karimi, CEO of Cemvita, said in a news release. “Our vision is to combine the innovation Cemvita is known for with Brazil’s expertise and resources to create an ecosystem where waste becomes opportunity and sustainability drives growth. By joining forces with Brazilian partners, Cemvita aims to build on Brazil’s storied history in the bioeconomy while laying the groundwork for a circular and sustainable future.”

The Fuel of the Future Law mandates an increase in the biodiesel content of diesel fuel, starting from 15 percent in March and increasing to 20 percent by 2030. It also requires the adoption of Sustainable Aviation Fuel (SAF) and for domestic flights to reduce greenhouse gas emissions by 1 percent starting in 2027, growing to 10 percent reduction by 2037.

Cemvita agreed to a 20-year contract that specified it would supply up to 50 million gallons of SAF annually to United Airlines in 2023.

"This is all made possible by our innovative technology, which transforms carbon waste into value,” Marcio Da Silva, VP of Innovation, said in a news release. “Unlike traditional methods, it requires neither a large land footprint nor clean freshwater, ensuring minimal environmental impact. At the same time, it produces high-value green chemicals—such as sustainable oils and biofuels—without competing with the critical resources needed for food production."

In 2024, Cemvita became capable of generating 500 barrels per day of sustainable oil from carbon waste at its first commercial plant. As a result, Cemvita quadrupled output at its Houston plant. The company had originally planned to reach this milestone in 2029.

---

This story originally appeared on our sister site, EnergyCapitalHTX.